- IBDEI3E7 ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,57047,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57047,1,3,0)
- ;;=3^DM Type 2 w/ DM Dermatitis
- ;;^UTILITY(U,$J,358.3,57047,1,4,0)
- ;;=4^E11.620
- ;;^UTILITY(U,$J,358.3,57047,2)
- ;;=^5002655
- ;;^UTILITY(U,$J,358.3,57048,0)
- ;;=E11.621^^264^2849^94
- ;;^UTILITY(U,$J,358.3,57048,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57048,1,3,0)
- ;;=3^DM Type 2 w/ Foot Ulcer
- ;;^UTILITY(U,$J,358.3,57048,1,4,0)
- ;;=4^E11.621
- ;;^UTILITY(U,$J,358.3,57048,2)
- ;;=^5002656
- ;;^UTILITY(U,$J,358.3,57049,0)
- ;;=E11.622^^264^2849^99
- ;;^UTILITY(U,$J,358.3,57049,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57049,1,3,0)
- ;;=3^DM Type 2 w/ Skin Ulcer
- ;;^UTILITY(U,$J,358.3,57049,1,4,0)
- ;;=4^E11.622
- ;;^UTILITY(U,$J,358.3,57049,2)
- ;;=^5002657
- ;;^UTILITY(U,$J,358.3,57050,0)
- ;;=E11.630^^264^2849^98
- ;;^UTILITY(U,$J,358.3,57050,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57050,1,3,0)
- ;;=3^DM Type 2 w/ Periodontal Disease
- ;;^UTILITY(U,$J,358.3,57050,1,4,0)
- ;;=4^E11.630
- ;;^UTILITY(U,$J,358.3,57050,2)
- ;;=^5002659
- ;;^UTILITY(U,$J,358.3,57051,0)
- ;;=E11.641^^264^2849^96
- ;;^UTILITY(U,$J,358.3,57051,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57051,1,3,0)
- ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
- ;;^UTILITY(U,$J,358.3,57051,1,4,0)
- ;;=4^E11.641
- ;;^UTILITY(U,$J,358.3,57051,2)
- ;;=^5002661
- ;;^UTILITY(U,$J,358.3,57052,0)
- ;;=E11.649^^264^2849^97
- ;;^UTILITY(U,$J,358.3,57052,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57052,1,3,0)
- ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
- ;;^UTILITY(U,$J,358.3,57052,1,4,0)
- ;;=4^E11.649
- ;;^UTILITY(U,$J,358.3,57052,2)
- ;;=^5002662
- ;;^UTILITY(U,$J,358.3,57053,0)
- ;;=E11.65^^264^2849^95
- ;;^UTILITY(U,$J,358.3,57053,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57053,1,3,0)
- ;;=3^DM Type 2 w/ Hyperglycemia
- ;;^UTILITY(U,$J,358.3,57053,1,4,0)
- ;;=4^E11.65
- ;;^UTILITY(U,$J,358.3,57053,2)
- ;;=^5002663
- ;;^UTILITY(U,$J,358.3,57054,0)
- ;;=G56.41^^264^2849^59
- ;;^UTILITY(U,$J,358.3,57054,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57054,1,3,0)
- ;;=3^Causalgia Rt Upper Limb
- ;;^UTILITY(U,$J,358.3,57054,1,4,0)
- ;;=4^G56.41
- ;;^UTILITY(U,$J,358.3,57054,2)
- ;;=^5004030
- ;;^UTILITY(U,$J,358.3,57055,0)
- ;;=G56.42^^264^2849^58
- ;;^UTILITY(U,$J,358.3,57055,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57055,1,3,0)
- ;;=3^Causalgia Lt Upper Limb
- ;;^UTILITY(U,$J,358.3,57055,1,4,0)
- ;;=4^G56.42
- ;;^UTILITY(U,$J,358.3,57055,2)
- ;;=^5004031
- ;;^UTILITY(U,$J,358.3,57056,0)
- ;;=I65.21^^264^2849^124
- ;;^UTILITY(U,$J,358.3,57056,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57056,1,3,0)
- ;;=3^Occlusion & Stenosis Rt Carotid Artery
- ;;^UTILITY(U,$J,358.3,57056,1,4,0)
- ;;=4^I65.21
- ;;^UTILITY(U,$J,358.3,57056,2)
- ;;=^5007360
- ;;^UTILITY(U,$J,358.3,57057,0)
- ;;=I65.22^^264^2849^123
- ;;^UTILITY(U,$J,358.3,57057,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57057,1,3,0)
- ;;=3^Occlusion & Stenosis Lt Carotid Artery
- ;;^UTILITY(U,$J,358.3,57057,1,4,0)
- ;;=4^I65.22
- ;;^UTILITY(U,$J,358.3,57057,2)
- ;;=^5007361
- ;;^UTILITY(U,$J,358.3,57058,0)
- ;;=I65.23^^264^2849^122
- ;;^UTILITY(U,$J,358.3,57058,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57058,1,3,0)
- ;;=3^Occlusion & Stenosis Bil Carotid Arteries
- ;;^UTILITY(U,$J,358.3,57058,1,4,0)
- ;;=4^I65.23
- ;;^UTILITY(U,$J,358.3,57058,2)
- ;;=^5007362
- ;;^UTILITY(U,$J,358.3,57059,0)
- ;;=I63.131^^264^2849^66
- ;;^UTILITY(U,$J,358.3,57059,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,57059,1,3,0)
- ;;=3^Cereb Infarc d/t Rt Carotid Artery Embolism
- ;;^UTILITY(U,$J,358.3,57059,1,4,0)
- ;;=4^I63.131
- ;;^UTILITY(U,$J,358.3,57059,2)
- ;;=^5007308
- ;;^UTILITY(U,$J,358.3,57060,0)
- ;;=I63.132^^264^2849^64
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3E7 3990 printed Feb 19, 2025@00:13:28 Page 2
- IBDEI3E7 ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,57047,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,57047,1,3,0)
- +4 ;;=3^DM Type 2 w/ DM Dermatitis
- +5 ;;^UTILITY(U,$J,358.3,57047,1,4,0)
- +6 ;;=4^E11.620
- +7 ;;^UTILITY(U,$J,358.3,57047,2)
- +8 ;;=^5002655
- +9 ;;^UTILITY(U,$J,358.3,57048,0)
- +10 ;;=E11.621^^264^2849^94
- +11 ;;^UTILITY(U,$J,358.3,57048,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,57048,1,3,0)
- +14 ;;=3^DM Type 2 w/ Foot Ulcer
- +15 ;;^UTILITY(U,$J,358.3,57048,1,4,0)
- +16 ;;=4^E11.621
- +17 ;;^UTILITY(U,$J,358.3,57048,2)
- +18 ;;=^5002656
- +19 ;;^UTILITY(U,$J,358.3,57049,0)
- +20 ;;=E11.622^^264^2849^99
- +21 ;;^UTILITY(U,$J,358.3,57049,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,57049,1,3,0)
- +24 ;;=3^DM Type 2 w/ Skin Ulcer
- +25 ;;^UTILITY(U,$J,358.3,57049,1,4,0)
- +26 ;;=4^E11.622
- +27 ;;^UTILITY(U,$J,358.3,57049,2)
- +28 ;;=^5002657
- +29 ;;^UTILITY(U,$J,358.3,57050,0)
- +30 ;;=E11.630^^264^2849^98
- +31 ;;^UTILITY(U,$J,358.3,57050,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,57050,1,3,0)
- +34 ;;=3^DM Type 2 w/ Periodontal Disease
- +35 ;;^UTILITY(U,$J,358.3,57050,1,4,0)
- +36 ;;=4^E11.630
- +37 ;;^UTILITY(U,$J,358.3,57050,2)
- +38 ;;=^5002659
- +39 ;;^UTILITY(U,$J,358.3,57051,0)
- +40 ;;=E11.641^^264^2849^96
- +41 ;;^UTILITY(U,$J,358.3,57051,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,57051,1,3,0)
- +44 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
- +45 ;;^UTILITY(U,$J,358.3,57051,1,4,0)
- +46 ;;=4^E11.641
- +47 ;;^UTILITY(U,$J,358.3,57051,2)
- +48 ;;=^5002661
- +49 ;;^UTILITY(U,$J,358.3,57052,0)
- +50 ;;=E11.649^^264^2849^97
- +51 ;;^UTILITY(U,$J,358.3,57052,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,57052,1,3,0)
- +54 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
- +55 ;;^UTILITY(U,$J,358.3,57052,1,4,0)
- +56 ;;=4^E11.649
- +57 ;;^UTILITY(U,$J,358.3,57052,2)
- +58 ;;=^5002662
- +59 ;;^UTILITY(U,$J,358.3,57053,0)
- +60 ;;=E11.65^^264^2849^95
- +61 ;;^UTILITY(U,$J,358.3,57053,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,57053,1,3,0)
- +64 ;;=3^DM Type 2 w/ Hyperglycemia
- +65 ;;^UTILITY(U,$J,358.3,57053,1,4,0)
- +66 ;;=4^E11.65
- +67 ;;^UTILITY(U,$J,358.3,57053,2)
- +68 ;;=^5002663
- +69 ;;^UTILITY(U,$J,358.3,57054,0)
- +70 ;;=G56.41^^264^2849^59
- +71 ;;^UTILITY(U,$J,358.3,57054,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,57054,1,3,0)
- +74 ;;=3^Causalgia Rt Upper Limb
- +75 ;;^UTILITY(U,$J,358.3,57054,1,4,0)
- +76 ;;=4^G56.41
- +77 ;;^UTILITY(U,$J,358.3,57054,2)
- +78 ;;=^5004030
- +79 ;;^UTILITY(U,$J,358.3,57055,0)
- +80 ;;=G56.42^^264^2849^58
- +81 ;;^UTILITY(U,$J,358.3,57055,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,57055,1,3,0)
- +84 ;;=3^Causalgia Lt Upper Limb
- +85 ;;^UTILITY(U,$J,358.3,57055,1,4,0)
- +86 ;;=4^G56.42
- +87 ;;^UTILITY(U,$J,358.3,57055,2)
- +88 ;;=^5004031
- +89 ;;^UTILITY(U,$J,358.3,57056,0)
- +90 ;;=I65.21^^264^2849^124
- +91 ;;^UTILITY(U,$J,358.3,57056,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,57056,1,3,0)
- +94 ;;=3^Occlusion & Stenosis Rt Carotid Artery
- +95 ;;^UTILITY(U,$J,358.3,57056,1,4,0)
- +96 ;;=4^I65.21
- +97 ;;^UTILITY(U,$J,358.3,57056,2)
- +98 ;;=^5007360
- +99 ;;^UTILITY(U,$J,358.3,57057,0)
- +100 ;;=I65.22^^264^2849^123
- +101 ;;^UTILITY(U,$J,358.3,57057,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,57057,1,3,0)
- +104 ;;=3^Occlusion & Stenosis Lt Carotid Artery
- +105 ;;^UTILITY(U,$J,358.3,57057,1,4,0)
- +106 ;;=4^I65.22
- +107 ;;^UTILITY(U,$J,358.3,57057,2)
- +108 ;;=^5007361
- +109 ;;^UTILITY(U,$J,358.3,57058,0)
- +110 ;;=I65.23^^264^2849^122
- +111 ;;^UTILITY(U,$J,358.3,57058,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,57058,1,3,0)
- +114 ;;=3^Occlusion & Stenosis Bil Carotid Arteries
- +115 ;;^UTILITY(U,$J,358.3,57058,1,4,0)
- +116 ;;=4^I65.23
- +117 ;;^UTILITY(U,$J,358.3,57058,2)
- +118 ;;=^5007362
- +119 ;;^UTILITY(U,$J,358.3,57059,0)
- +120 ;;=I63.131^^264^2849^66
- +121 ;;^UTILITY(U,$J,358.3,57059,1,0)
- +122 ;;=^358.31IA^4^2
- +123 ;;^UTILITY(U,$J,358.3,57059,1,3,0)
- +124 ;;=3^Cereb Infarc d/t Rt Carotid Artery Embolism
- +125 ;;^UTILITY(U,$J,358.3,57059,1,4,0)
- +126 ;;=4^I63.131
- +127 ;;^UTILITY(U,$J,358.3,57059,2)
- +128 ;;=^5007308
- +129 ;;^UTILITY(U,$J,358.3,57060,0)
- +130 ;;=I63.132^^264^2849^64